AGM has launched its own range of graphene-enhanced anti-corrosion paints alongside another high-performance non-metal additive.
Applied Graphene Materials (AGM) has introduced two new product developments in quick succession, continuing to demonstrate its commitment to innovation.
Following exceptional results achieved through extensive internal research and testing, AGM has launched a range of industrial anti-corrosion paints incorporating its own Genable graphene additives. The two epoxy-based prototype primer systems represent an easy way for those considering the adoption of graphene to quickly test and evaluate its potential benefits.
The Genable Epoxy primer is a C3-classified hybrid product that contains graphene and a zinc phosphate additive to allow the end user to benefit from the synergies offered by both systems in standard applications, such as urban and industrial environments. The Genable CX primer is a high-performance hybrid system based on graphene and aluminium chemistries which allows to protect surfaces against corrosion even in harsh environments, such as offshore and marine applications.
Additionally, AGM has also introduced a range of non-metal, active anti-corrosion graphene to extend its Genable 3000 dispersion series. Using a combination of graphene with traditional sacrificial additives, the new hybrid range, which is free of metals and VOC, maximizes synergies between complementary systems to offer the paint and coatings industry excellent corrosion protection. The new graphene additives are based on the company's established Genable technology, which improves performance such as chemical resistance, barrier properties and anti-corrosion properties.
Genable 3100 and Genable 3105 are optimized, formulation-ready dispersions that are easy to formulate, safe to incorporate and stabilized in a standard epoxy resin; Genable 3120 offers a more sustainable option in an environmentally friendly bio-based epoxy resin to increase anti-corrosion performance while contributing to environmental goals.
Adrian Potts, Chief Executive Officer for AGM said: “We are pleased to be able to launch these new Genable products, which we anticipate will help further accelerate the adoption of graphene nanoplatelet technology in the industry. Our technology development programmes have focused on extensive testing and evaluation for a range of applications, and this experience is valuable to guide customers in the use of our products.”